Nike Is Down 77% From Its Peak. Should You Buy Before It Reports Earnings on Oct. 1?

Nike's China revenue fell 12% in the latest quarter, while its shares are down 77% from their late-2021 peak and roughly 44% year-to-date in 2026. The company is pursuing a turnaround through renewed wholesale relationships, lower inventory, and sharper focus on priority sports and cities, supported by roughly $9B in cash and short-term investments and a $0.41 quarterly dividend. Management expects gross margin expansion to resume in fiscal Q2 2027, but the article characterizes the recovery as prolonged and execution-dependent ahead of Oct. 1 earnings.

Analysis

The wholesale rebuild is economically necessary but unlikely to produce a clean earnings inflection: restoring shelf space typically requires markdown support, retailer incentives and less favorable channel mix before it improves sell-through. That creates a near-term risk that revenue stabilization is purchased at the expense of gross margin, working capital, or both. The more investable KPI is not headline sales, but wholesale order growth alongside declining promotional intensity and inventory days; without all three, the reset is merely channel shifting.

China is a structural share issue rather than simply a macro-demand issue. Local brands including Anta Sports (2020 HK) and Li Ning (2331 HK) can use domestic athlete endorsements, faster local merchandising and lower perceived political risk to hold share even if consumer spending improves. A weaker NKE also creates a relative opening for adidas (ADS GR), whose brand momentum and wholesale execution could capture multi-brand retailer attention while Nike reallocates distribution.

The Oct. 1 print is a binary event, but a positive surprise would need credible evidence that fiscal-2027 margin recovery is achievable without another demand reset. Given the depressed equity base, downside may be less about a single weak quarter than a guidance change implying that margin normalization slips beyond the next fiscal year; that would challenge the market's ability to underwrite a premium global-brand multiple. Conversely, a sequential improvement in Greater China sell-through, lower inventory, and maintained gross-margin timing could trigger a 1-3 month short-covering rally, even before a fundamental turnaround is visible.

Contrarian view: consensus may be too focused on the direct-to-consumer reversal as a cure-all. Wholesale can improve reach, but it also gives retailers greater negotiating leverage and makes the brand more exposed to the promotional environment. The durable 6-18 month upside case requires product heat in running, training and performance categories—not simply broader distribution—so the relevant falsifier is continued market-share loss despite improved availability.

Key Decisions for Investors

• Remain neutral NKE into Oct. 1 unless channel checks show both improving wholesale preorders and lower promotional activity; the article provides no independently verifiable evidence that either is occurring. Treat a maintained fiscal-2027 gross-margin expansion outlook plus better inventory metrics as the trigger for a tactical 1-3 month long.
• For portfolios requiring athletic-footwear exposure, prefer a relative long ADS GR / short NKE pair over the next 3-6 months. The trade isolates execution divergence: adidas benefits if retailers diversify shelf space, while NKE remains exposed to a margin-dilutive channel rebuild. Exit if NKE reports clear China share stabilization and wholesale growth without a gross-margin guide reduction.
• Avoid selling NKE downside volatility ahead of earnings. The key risk is not reported demand alone but a delayed margin-recovery timeline, which could cause another valuation reset; defined-risk put spreads are preferable to an outright short only if implied volatility is below the expected post-earnings move.
• Monitor Anta Sports (2020 HK) and Li Ning (2331 HK) quarterly China sell-through and inventory commentary as leading indicators for NKE's regional recovery. Continued local-brand growth through the next two reporting cycles would weaken the thesis that Nike's China pressure is cyclical and argue against adding to NKE on valuation alone.